The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Collaborating with low- and middle-income countries: Experience from two of the United Kingdom’s comprehensive cancer centers.
 
Emma Foreman
Honoraria - Amgen Astellas BioPharma; AstraZeneca; Bristol-Myers Squibb; Ipsen
 
Isla Leslie
No Relationships to Disclose
 
Hannah Lyons
No Relationships to Disclose
 
Katherine Piddock
No Relationships to Disclose
 
Anguraj Sadanandam
Consulting or Advisory Role - Ploughshare Innovations
Research Funding - Bristol-Myers Squibb; Merck KGaA; Pierre Fabre
Patents, Royalties, Other Intellectual Property - • Prognostic and treatment response prediction in gastric cancer – Priority Patent CSC/BP7295892; Patent - ‘Colorectal cancer classification with differential prognosis and personalized therapeutic responses’ (patent number PCT/IB2013/060416).; Patent - “Molecular predictors of therapeutic response to specific anti-cancer agents” (patent number US9506926B2).; Patent - Patient classification and prognostic method (GEP-NET) – Priority Patent - EP18425009.0
 
Alison Sanneh
No Relationships to Disclose
 
Susannah Jane Stanway
Stock and Other Ownership Interests - AstraZeneca (I)
 
Julie Webb
No Relationships to Disclose
 
Richard Cowan
Consulting or Advisory Role - Helsinn Therapeutics; Kyowa Kirin Pharmaceutical Development